-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Srixon Announces Buy 2, Get 1 Free Golf Ball Promotion
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
-
Who Is the Best Spanish-Speaking Private Investigator in Sacramento?
-
Healixa Turns Patents Into Products: FrostPulse(TM) Delivered and Five Eternal Spring(TM) Units Enter Production
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
-
Nearly Half of Transformation Initiatives Face a 'Momentum Gap' That Puts Value at Risk, NSP & Company Study Finds
-
CXAI Expands Agentic AI Reach into Mid-Market Through EngineRoom's Simpro Partnership
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Agency Guacamole's 10th B.L.N.D. Event Brought Industry Leaders Together for a Conversation on the Evolution of Diversity and Inclusion in Beauty
-
From Pilot to Production: InHand Networks' Practical Approach to Industrial Edge AI
'Master key' vaccine technique may 'prevent next pandemic': researchers
Known by acronyms that need no explanation, viruses like Covid, Sars and Ebola conjure up images of medics in protective suits and spark fear in populations worldwide.
Vaccines for individual viruses have provided some relief, but new strains pose a constant challenge.
Now, new AI-aided vaccine technology developed by scientists at Cambridge University offer potential immunity against whole families of viruses and could even prevent the next pandemic, according to researchers.
Professor Jonathan Heeney of Cambridge University likened the new technique to having the "master key" for an apartment block.
The main problem with vaccines, he said, was that they were "all historic" so the strain you are vaccinated with might not be the one you end up being exposed to in six months time.
Vaccines were "always chasing the virus", the project lead researcher told AFP in an interview.
"So we're getting rid of that variability by making something that's across the board recognisable by your immune system that should cover you from all these eventualities ... a real big paradigm change," he said.
Canadian Heeney, of the lab of viral zoonotics at Cambridge University's Department of Veterinary Medicine, began work on the project after the 2013-16 Ebola outbreak in west Africa where he was then based.
- 'Horse bolted' -
Ebola had previously been seen in the central African Democratic Republic of Congo, not in west Africa and it was initially misidentified as lassa fever, gastroenteritis or cholera.
The west African outbreak eventually claimed around 11,300 lives, according to the World Health Organization (WHO).
But Heeney said three or four months were spent trying to discover what it was before work could even begin on a vaccine.
"In that time, it spread from Guinea, to Sierra Leone to Liberia, three different countries quickly. The horse had bolted, the fire was raging," he said, adding many health workers were among the victims.
Returning to Cambridge after the west African outbreak, Heeney said there was a determination that "we've got to change the way this works, we can't go through it again".
Harnessing early AI, he said, his team used all the information they could get about various viruses and brought it together.
This allowed them to look for the "similarities and the differences in the important parts of the virus that the immune system responds to", recognising not just one variant but all of them.
The new technology was all the more vital given the frequency with which viruses are now emerging due to population growth, greater movement across borders and human encroachment on animal habitats, he said.
Viruses that had previously existed harmlessly, residing in animals that had grown resistant, were coming into contact with a new species, humans, and "wow, there's no immunity, no natural defences... and the virus goes crazy", he said.
- 'Change the future' -
A trial involving 39 volunteers -- sponsored by the University Hospital Southampton and published in the Journal of Infection -- found "no significant safety concerns" with the universal Sarbeco coronavirus vaccine made using the AI-aided technology.
The vaccine developed by the Cambridge scientists and biotechnoloy firm DIOSynVax will now move to larger tests.
Plagues have existed throughout history, said Heeney, from the Black Death of the Middle Ages ages to the 1918-20 influenza pandemic which killed an estimated 25-50 million globally.
Heeney's most pressing concern was a potential influenza outbreak, he said, describing it as one of the "trickier" viruses.
But he was hopeful the new technology could help prevent another deadly pandemic.
"Now, there's a whole different layer of AI, and we have a team using the latest AI technology ... to build a real powerful platform so we can work even faster with more data," he said.
"This, I hope is the start of a whole new era of vaccine manufacturing ... From my point of view it's about proving this technology to the world that it's safe, that it's more effective and actually jump on board.
"I think this opens the door to a whole new kind of technology. Hopefully that can change the future," he said.
D.Lopez--AT